IN2014DN08407A - - Google Patents
Info
- Publication number
- IN2014DN08407A IN2014DN08407A IN8407DEN2014A IN2014DN08407A IN 2014DN08407 A IN2014DN08407 A IN 2014DN08407A IN 8407DEN2014 A IN8407DEN2014 A IN 8407DEN2014A IN 2014DN08407 A IN2014DN08407 A IN 2014DN08407A
- Authority
- IN
- India
- Prior art keywords
- methods
- compositions
- immunostimulatory cell
- cell compositions
- activated immunostimulatory
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 3
- 230000003308 immunostimulating effect Effects 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/464838—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- AIDS & HIV (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261611180P | 2012-03-15 | 2012-03-15 | |
PCT/IB2013/000935 WO2013136191A1 (en) | 2012-03-15 | 2013-03-13 | Activated immunostimulatory cell composition for therapy of infection |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN08407A true IN2014DN08407A (ru) | 2015-05-08 |
Family
ID=48483110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN8407DEN2014 IN2014DN08407A (ru) | 2012-03-15 | 2013-03-13 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20150071892A1 (ru) |
EP (1) | EP2825182A1 (ru) |
JP (1) | JP2015509974A (ru) |
CA (1) | CA2864838A1 (ru) |
IN (1) | IN2014DN08407A (ru) |
MX (1) | MX2014010893A (ru) |
RU (1) | RU2014140795A (ru) |
WO (1) | WO2013136191A1 (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012032418A2 (en) | 2010-09-09 | 2012-03-15 | Macrocure, Ltd. | Activated leukocyte conditioned supernatant and uses for wound healing |
EP3516045A1 (en) * | 2016-09-23 | 2019-07-31 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same |
CN111065400A (zh) * | 2017-10-03 | 2020-04-24 | 公益财团法人东京都医学总合研究所 | 抗流感药物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7713739B1 (en) | 2000-11-17 | 2010-05-11 | Novartis Vaccines And Diagnostics, Inc. | Microparticle-based transfection and activation of dendritic cells |
KR101131727B1 (ko) | 2004-06-11 | 2012-03-28 | 가톨릭대학교 산학협력단 | CEA-특이적인 세포독성 T세포를 생성하는 재조합 아데노바이러스 AdVCEA로 트랜스덕션된 수지상세포, 이를 포함하는 백신 및 약제학적 조성물 |
EP1748067A1 (en) | 2005-07-29 | 2007-01-31 | Institut Pasteur | Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes |
KR101548783B1 (ko) | 2009-03-05 | 2015-08-31 | 매크로큐어, 엘티디. | 활성화된 백혈구 조성물 |
-
2013
- 2013-03-13 CA CA2864838A patent/CA2864838A1/en not_active Abandoned
- 2013-03-13 MX MX2014010893A patent/MX2014010893A/es unknown
- 2013-03-13 RU RU2014140795A patent/RU2014140795A/ru not_active Application Discontinuation
- 2013-03-13 IN IN8407DEN2014 patent/IN2014DN08407A/en unknown
- 2013-03-13 US US14/385,126 patent/US20150071892A1/en not_active Abandoned
- 2013-03-13 EP EP13724621.1A patent/EP2825182A1/en not_active Withdrawn
- 2013-03-13 WO PCT/IB2013/000935 patent/WO2013136191A1/en active Application Filing
- 2013-03-13 JP JP2014561542A patent/JP2015509974A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
MX2014010893A (es) | 2015-06-23 |
CA2864838A1 (en) | 2013-09-19 |
US20150071892A1 (en) | 2015-03-12 |
JP2015509974A (ja) | 2015-04-02 |
EP2825182A1 (en) | 2015-01-21 |
WO2013136191A1 (en) | 2013-09-19 |
RU2014140795A (ru) | 2016-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2017008819A (es) | Anticuerpos anti-cd47 y usos de los mismos. | |
IN2012DN01920A (ru) | ||
TN2012000414A1 (en) | Forms of rifaximin and uses thereof | |
IN2014CN04251A (ru) | ||
PT2750682T (pt) | Composição compreendendo a flora intestinal cultivada anaerobiamente | |
NZ629697A (en) | Human anti-cd27 antibodies, methods and uses | |
MX2016008448A (es) | Conjugados de var2csa-farmaco. | |
MX2017001279A (es) | Usos y composiciones de la flagelina. | |
EA201391611A1 (ru) | Вызывающие иммунную толерантность синтетические наноносители для терапевтического лечения аллергии | |
ZA201307394B (en) | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses | |
EA201300585A1 (ru) | Иммуномодулирующие олигонуклеотиды | |
IN2014DN11201A (ru) | ||
ZA201500099B (en) | Radiation-curable ,stable nail gel compositions and methods of preparation and use | |
IN2014DN06104A (ru) | ||
MX2015003701A (es) | Composiciones para tratamiento. | |
HK1218880A1 (zh) | 增强對艾美球蟲的免疫應答或限制艾美球蟲感染的組合物和方法 | |
PL2892556T3 (pl) | Kompozycje i sposoby odnoszące się do leczenia chorób | |
EA201401117A1 (ru) | Композиции, содержащие пробиотики и комплекс пчелиной пыльцы/глины, способ их приготовления и их применение в питании и терапии | |
EP2878666A4 (en) | INDUSTRIAL PREPARATION OF NATURAL KILLING CELLS (NKS) AND INJECTION USING HUMAN ALLOGENIC CARYOCYTES | |
IN2014DN08407A (ru) | ||
IN2014DN08093A (ru) | ||
MX2013014420A (es) | Composiciones en gel. | |
AU346524S (en) | Spacer | |
SG11201504779YA (en) | Methods and compositions relating to treatment of cancer | |
EP2838543A4 (en) | IMMUNOSTIMULANT COMPOSITIONS AND METHODS OF MAKING |